Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cellulitis and erysipelas

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sepsis or deep destructive infection

Shock, rapidly progressive pain, bullae, skin anaesthesia, crepitus or pain out of proportion suggests sepsis or necrotising infection rather than routine cellulitis.

Action: Use ABCDE, mark the affected area, obtain urgent blood tests and cultures without delaying intravenous therapy, involve surgery immediately and escalate to critical care when physiology is unstable.

Synopsis

Recognise non-purulent bacterial skin infection, grade severity, distinguish common mimics and prescribe safe narrow therapy while addressing portals of entry and recurrence.

  • Cellulitis is a spreading infection of dermis and subcutaneous tissue; erysipelas is more superficial, raised and sharply demarcated.
  • Typical findings are unilateral warmth, erythema, tenderness and swelling, sometimes with lymphangitis or systemic upset.
  • Bilateral red legs are rarely bilateral cellulitis; venous stasis, lipodermatosclerosis and oedema are common mimics.
  • Outline the margin and document observations, pain, portal of entry and baseline limb function before treatment.
  • For uncomplicated adult disease, NICE first choice is flucloxacillin 500 mg to 1 g four times daily for five to seven days.
  • Clarithromycin 500 mg twice daily is an option for penicillin allergy; erythromycin 500 mg four times daily is preferred in pregnancy when a macrolide is needed.
  • Initial redness may extend during the first 24 to 48 hours despite effective therapy, but worsening physiology or disproportionate pain is not expected.
  • Address tinea pedis, eczema, wounds, oedema and venous disease because antibiotics alone do not prevent recurrence.

Key red flags

Pain out of proportion or rapidly advancing oedema suggests necrotising soft-tissue infection.

Hypotension, confusion, tachypnoea, mottling or oliguria indicates sepsis-related organ dysfunction.

Crepitus, haemorrhagic bullae, skin anaesthesia or dusky necrosis requires immediate surgical assessment.

Periorbital swelling with painful eye movements, visual change or proptosis suggests orbital cellulitis.

Hand infection, human bite, diabetic foot disease or severe immune compromise requires a different specialist pathway.

Systemic severity

Fever, rigors, tachycardia, hypotension, delirium or reduced urine output indicates systemic involvement and possible sepsis.

Deep infection clues

Disproportionate pain, rapid spread, anaesthesia, bullae, crepitus or skin necrosis should override a reassuring superficial label.

Special anatomical site

Infection near an eye, hand, joint, surgical implant, diabetic ulcer or bite requires anatomy-specific assessment and often specialist input.

Investigation priorities

01
Clinical examination and marked marginFirst step

Define extent, severity, portal of entry and a reproducible baseline for reassessment.

Management branches

STABLEUse narrow oral treatment

Uncomplicated cellulitis is likely, physiology is stable and oral absorption and follow-up are reliable.

  1. Document the site, margin, pain, observations, portal of entry, allergy reaction, renal function and factors that alter organism risk.
  2. Give flucloxacillin 500 mg to 1 g orally four times daily for five to seven days when suitable, using a guideline-listed allergy alternative when needed.
  3. Elevate an affected limb, provide analgesia and treat fissures, tinea, eczema, wound care and oedema without applying topical antibiotics to intact skin.
  4. Arrange review if symptoms worsen rapidly or fail to begin improving within two to three days and provide sepsis and necrotising-infection safety-net advice.

Key medicines

FlucloxacillinGive 500 mg to 1 g orally four times daily for five to seven days for uncomplicated adult cellulitis; use intravenous dosing when severity requires admission.Clarify immediate penicillin allergy, adjust route to severity, review hepatic dysfunction and interactions, and extend beyond seven days only after clinical reassessment.
ClarithromycinGive 500 mg orally twice daily for five to seven days when penicillin allergy makes flucloxacillin unsuitable.Review QT prolongation, liver disease and interactions including statins, warfarin, colchicine and other CYP3A4 substrates; local macrolide resistance may alter suitability.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG141 Cellulitis and erysipelas antimicrobial prescribing
  • NICE NG253 Suspected sepsis in people aged 16 or over
  • NHS Cellulitis information

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom